Table 1.
Pap Test | Pelvic Exam | Clinical Breast Exam |
Sexually Transmitted Infections | |
---|---|---|---|---|
Screening Recommendation | Every 3 years for those aged 21–65; every 5 years starting at age 30 with hrHPV | Shared decision-making with patient; perform when indicated by medical necessity | Every 1–2 years for women aged 25–39 years old; annually for women over 40 | Test based on age and risk factors 1 |
Supporting Organizations | ACOG, ASCCP, SGO | ACOG, USPSTF | ACOG, NCCN | CDC |
Abbreviations: hrHPV = high-risk human papillomavirus, ACOG = American College of Obstetricians and Gynecologists, ASCCP = American Society for Colposcopy and Cervical Pathology, SGO = Society of Gynecologic Oncology, USPSTF = United States Preventative Services Task Force, NCCN = National Comprehensive Cancer Network, CDC = Centers for Disease Control and Prevention. 1 Chlamydia and gonorrhea for those less than 25 years old and sexually active or 25 and older with risk factors; Human immunodeficiency virus (HIV) for all women ages 13–64 and those who desire sexually transmitted infection (STI) screening.